Home
Products & Services
Support
About
Contact Us
FinancialContent is the trusted provider of stock market information to the media industry.
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Omeros Corp (NQ: OMER)
14.70 USD  +0.15 (+1.03%)
Official Closing Price  /  Updated: 4:51 PM EDT, Jul 23, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 239,700
Open 14.69
Bid (Size) 14.10 (2)
Ask (Size) 15.00 (20)
Prev. Close 14.55
Today's Range 14.35 - 14.85
52wk Range 10.30 - 27.00
Shares Outstanding 48,292,608
Dividend Yield N/A
Performance
YTD
+24.05%
+24.05%
1 Month
-10.26%
-10.26%
3 Month
-22.43%
-22.43%
6 Month
+10.69%
+10.69%
1 Year
-30.53%
-30.53%
Top News
More News
Omeros Announces Agreement with FDA on Primary Endpoint for Narsoplimab BLA in Stem Cell Transplant-Associated TMA
Omeros Corporation today announced agreement with the U.S. Food and Drug Administration (FDA) on the response-based primary endpoint for its pivotal trial to support the biologics license application... Read More
from Business Wire News Releases
Omeros Corporation Announces Assignment of Rapporteurs for European Marketing Authorization Application for Narsoplimab for Treatment of HSCT-TMA
Omeros Corporation (Nasdaq: OMER) today announced that the European Medicines Agency (EMA) has appointed rapporteurs for the company’s marketing authorization application (MAA) currently in preparation... Read More
from Business Wire News Releases
More News
Read More
Omeros to Present at the UBS Global Healthcare Conference
from Business Wire News Releases
Commit To Buy Omeros Corp At $14, Earn 31.5% Annualized Using Options
category Stocks
from Market News Video
Omeros Corporation Reports First Quarter 2019 Financial Results
from Business Wire News Releases
Notable Thursday Option Activity: TNDM, OMER, GDI
category Stocks
from Market News Video
Omeros, FDA Agree On Endpoint For Pivotal Trial Of Small Blood Vessel Damage Treatment
category News , Biotech , FDA , and 5 more.
from Benzinga
Add Up The Parts: IHE Could Be Worth $180
category ETFs
from ETF Channel
Notable Monday Option Activity: SRDX, ECOL, OMER
category Stocks
from Market News Video
Notable Tuesday Option Activity: VZ, KBH, OMER
category Stocks
from Market News Video
Omeros Corp Up 16.2% Since SmarTrend Uptrend Call (OMER)
from Comtex SmarTrend® News Briefs
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
   
© Copyright FinancialContent Services, Inc.